Pain in malignant hematology

References

• Stalfelt AM, Brodin H, Pettersson S, Eklof A. The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain. Leuk. Res.27, 481–488 (2003).
   PubMed Web of Science ®Google Scholar
• Johnsen AT, Tholstrup D, Petersen MA, Pedersen L, Groenvold M. Health related quality of life in a nationally representative sample of haematological patients. Eur. J. Haematol.83(2), 139–148 (2009).
   PubMed Web of Science ®Google Scholar
• Cartoni C, Efficace F, Tendas A et al. Assessing symptoms in hematology from the patients’ perspective: feasibility of a patient reported instrument in clinical research. Haematologica95(Suppl. 2), 188 (2010) (Abstract 0463).
   Google Scholar
• Van Cleve L, Bossert E, Beecroft P, Adlard K, Alvarez O, Savedra MC. The pain experience of children with leukemia during the first year after diagnosis. Nurs. Res.53(1), 1–10 (2004).
   PubMed Web of Science ®Google Scholar
• Morselli M, Bandieri E, Zanin R et al. Pain and emotional distress in leukemia patients at diagnosis. Leuk. Res.34(2), e67–e68 (2010).
   PubMed Web of Science ®Google Scholar
• Niscola P, Cartoni C, Romani C et al. Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey. Ann. Hematol.86(9), 671–676 (2007).
   PubMed Web of Science ®Google Scholar
• Niscola P, Romani C, Cartoni C et al. Epidemiology of pain in hospital haematological setting: an Italian survey. Leuk. Res.32(1), 197–198 (2008).
   PubMed Web of Science ®Google Scholar
• Niscola P. Effective pain management in hematological malignancies. Expert Rev. Hematol.2(3), 219–222 (2009).
   PubMed Web of Science ®Google Scholar
• Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann. Oncol.19(12), 1985–1991 (2008).
   PubMed Web of Science ®Google Scholar
• Apolone G, Corli O, Caraceni A et al. Cancer Pain Outcome Research Study Group (CPORSG) Investigators. Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br. J. Cancer100(10), 1566–1574 (2009).
   PubMed Web of Science ®Google Scholar
• Woolf CJ. American College of Physicians; American Physiological Society. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann. Intern. Med.140(6), 441–451 (2004).
   PubMed Web of Science ®Google Scholar
• Fine PG, Miaskowski C, Paice JA. Meeting the challenges in cancer pain management. J. Support Oncol.2(6 Suppl. 4), 5–22 (2004).
   PubMedGoogle Scholar
• Niscola P, Arcuri E, Giovannini M et al. Pain syndromes in haematological malignancies: an overview. Hematol. J.5(4), 293–303 (2004).
   PubMedGoogle Scholar
• Sabino MA, Mantyh PW. Pathophysiology of bone cancer pain. J. Support Oncol.3(1), 15–24 (2005).
   PubMedGoogle Scholar
• Lossignol DA, Dumitrescu C. Breakthrough pain: progress in management. Curr. Opin. Oncol.22(4), 302–306 (2010).
   PubMed Web of Science ®Google Scholar
• Davis MP, Walsh D. Cancer pain: how to measure the fifth vital sign. Cleve. Clin. J. Med.71(8), 625–632 (2004).
   PubMed Web of Science ®Google Scholar
• Chauhan A, Weiss J, Warrier R. Effective management of pain in pediatric hematology and oncology. Asian Pac. J. Cancer Prev.11(2), 577–579 (2010).
   PubMedGoogle Scholar
• Bennet MI. Diagnosing neuropathic pain in clinical practice. In: Neuropathic Pain. Oxford University Press, Oxford, UK, 25–35 (2006).
   Google Scholar
• Niscola P, Scaramucci L, Romani C et al. Pain management in multiple myeloma. Expert Rev. Anticancer Ther.10(3), 415–425 (2010).
   PubMed Web of Science ®Google Scholar
• Roodman GD. Pathogenesis of myeloma bone disease. Leukemia23(3), 435–441 (2009).
   PubMed Web of Science ®Google Scholar
• Takasaki H, Kanamori H, Takabayashi M et al. Non-Hodgkin’s lymphoma presenting as multiple bone lesions and hypercalcemia. Am. J. Hematol.81(6), 439–442 (2006).
   PubMed Web of Science ®Google Scholar
• Quintini G, Barbera V, Franco V. Bone remodeling in acute myeloid leukemia. Haematologica86, 1006 (2001).
   PubMed Web of Science ®Google Scholar
• Sinigaglia R, Gigante C, Bisinella G, Varotto S, Zanesco L, Turra S. Musculoskeletal manifestations in pediatric acute leukemia. J. Pediatr. Orthop.28(1), 20–28 (2008).
   PubMed Web of Science ®Google Scholar
• Jayanthan A, Miettunen PM, Incoronato A et al. Childhood acute lymphoblastic leukemia (ALL) presenting with severe osteolysis: a model to study leukemia-bone interactions and potential targeted therapeutics. Pediatr. Hematol. Oncol.27(3), 212–227 (2010).
   PubMed Web of Science ®Google Scholar
• Silberman J, Lonial S. Review of peripheral neuropathy in plasma cell disorders. Hematol. Oncol.26(2), 55–65 (2008).
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Baron R et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol.17(9), 1113–e88 (2010).
   PubMed Web of Science ®Google Scholar
• Davda R, Davies S, Kumaran T. Splenic irradiation in the management of Waldenstrom macroglobulinemia. Leuk. Lymphoma50(6), 1047–1049 (2009).
   PubMed Web of Science ®Google Scholar
• Mishchenko E, Tefferi A. Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt. Eur. J. Haematol.85(3), 192–199 (2010).
   PubMed Web of Science ®Google Scholar
• Coutaux A, Salomon L, Rosenheim M et al. Care related pain in hospitalized patients: a cross-sectional study. Eur. J. Pain12(1), 3–8 (2008).
   PubMed Web of Science ®Google Scholar
• Pinto L, Liu Z, Doan Q, Bernal M, Dubois R, Lyman G. Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials. Curr. Med. Res. Opin.23(9), 2283–2295 (2007).
   PubMed Web of Science ®Google Scholar
• Frieze DA. Musculoskeletal pain associated with corticosteroid therapy in cancer. Curr. Pain Headache Rep.14(4), 256–260 (2010).
   PubMed Web of Science ®Google Scholar
• Baker KS, Ness KK, Weisdorf D et al. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia24(12), 2039–2047 (2010).
   PubMed Web of Science ®Google Scholar
• Aricò M, Boccalatte MF, Silvestri D et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica88(7), 747–753 (2003).
   PubMed Web of Science ®Google Scholar
• Srinivasan D, Shetty S, Ashworth D, Grew N, Millar B. Orofacial pain – a presenting symptom of bisphosphonate associated osteonecrosis of the jaws. Br. Dent. J.203(2), 91–92 (2007).
   PubMed Web of Science ®Google Scholar
• Vahtsevanos K, Kyrgidis A, Verrou E et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J. Clin. Oncol.27(32), 5356–5362 (2009).
   PubMed Web of Science ®Google Scholar
• Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol.44(9), 857–869 (2008).
   PubMed Web of Science ®Google Scholar
• Niscola P, Romani C, Scaramucci L et al. Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies. Bone Marrow Transplant.41(9), 757–764 (2008).
   PubMed Web of Science ®Google Scholar
• Niscola P. Mucositis in malignant hematology. Expert Rev. Hematol.3(1), 57–65 (2010).
   PubMed Web of Science ®Google Scholar
• Flores-Calderón J, Exiga-Gonzaléz E, Morán-Villota S, Martín-Trejo J, Yamamoto-Nagano A. Acute pancreatitis in children with acute lymphoblasticleukemia treated with L-asparaginase. J. Pediatr. Hematol. Oncol.31(10), 790–793 (2009).
   PubMed Web of Science ®Google Scholar
• Diezi M, Nydegger A, Di Paolo ER, Kuchler H, Beck-Popovic M. Vincristine and intestinal pseudo-obstruction in children: report of 5 cases, literature review, and suggested management. J. Pediatr. Hematol. Oncol.32(4), e126–e130 (2010).
   PubMed Web of Science ®Google Scholar
• Chaudhry V, Cornblath DR, Polydefkis M, Ferguson A, Borrello I. Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy. J. Peripher. Nerv. Syst.13(4), 275–282 (2008).
   PubMed Web of Science ®Google Scholar
• Mohty B, El-Cheikh J, Yakoub-Agha I, Moreau P, Harousseau JL, Mohty M. Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations. Haematologica95(2), 311–319 (2010).
   PubMed Web of Science ®Google Scholar
• Cavaletti G, Jakubowiak AJ. Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies. Leuk. Lymphoma51(7), 1178–1187 (2010).
   PubMed Web of Science ®Google Scholar
• Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother. Pharmacol.63(5), 761–767 (2009).
   PubMed Web of Science ®Google Scholar
• Fujii N, Ikeda K, Koyama M et al. Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation. Int. J. Hematol.83(5), 459–461 (2006).
   PubMed Web of Science ®Google Scholar
• Jonsson OG, Sartain P, Ducore JM, Buchanan GR. Bone pain as an initial symptom of childhood acute lymphoblastic leukemia: association with nearly normal hematologic indexes. J. Pediatr.117, 233–237 (1990).
   PubMed Web of Science ®Google Scholar
• Bauduer F, Capdupuy C, Renoux M. Characteristics of deaths in a department of oncohaematology within a general hospital. A study of 81 cases. Support Care Cancer8(4), 302–306 (2000).
   PubMed Web of Science ®Google Scholar
• Hongo T, Watanabe C, Okada S et al. Analysis of the circumstances at the end of life in children with cancer: symptoms, suffering and acceptance. Pediatr. Int.45, 60–64 (2003).
   PubMed Web of Science ®Google Scholar
• Costantini M, Ripamonti C, Beccaro M et al. Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients’ life. Results of an Italian mortality follow-back survey. Ann. Oncol.20(4), 729–735 (2009).
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Mendoza TR, Wang XS et al. Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory. Cancer89(7), 1634–1646 (2000).
   PubMed Web of Science ®Google Scholar
• Geeta MG, Geetha P, Ajithkumar VT, Krishnakumar P, Kumar KS, Mathews L. Management of pain in leukemic children using the WHO analgesic ladder. Indian J. Pediatr.77(6), 665–668 (2010).
   PubMed Web of Science ®Google Scholar
• Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin. Proc.50(1), 29–40 (1975).
   PubMed Web of Science ®Google Scholar
• Zappasodi P, Corso A, Klersy C et al. Changes in multiple myeloma epidemiology in the last thirty years: a single centre experience. Eur. J. Cancer42(3), 396–402 (2006).
   PubMed Web of Science ®Google Scholar
• Lennert H. Pain therapy in multiple myeloma – clinical experience from an observational study. The Pain Clinic18(2)6, 131–136 (2006).
   Web of Science ®Google Scholar
• Lidén Y, Landgren O, Arnér S, Sjölund KF, Johansson E. Procedure-related pain among adult patients with hematologic malignancies. Acta Anaesthesiol. Scand.53(3), 354–363 (2009).
   PubMed Web of Science ®Google Scholar
• Högler W, Wehl G, van Staa T, Meister B, Klein-Franke A, Kropshofer G. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Pediatr. Blood Cancer48(1), 21–27 (2007).
   PubMed Web of Science ®Google Scholar
• Sonis ST, Elting LS, Keefe D et al., Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer100(9 Suppl.), 1995–2025 (2004).
   PubMed Web of Science ®Google Scholar
• Kyle RA, Yee GC, Somerfield MR et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J. Clin. Oncol.25(17), 2464–2472 (2007).
   PubMed Web of Science ®Google Scholar
• Meneses CF, de Freitas JC, Castro CG Jr, Copetti F, Brunetto AL. Safety of general anesthesia for lumbar puncture and bone marrow aspirate/biopsy in pediatric oncology patients. J. Pediatr. Hematol. Oncol.31(7), 465–470 (2009).
   PubMed Web of Science ®Google Scholar
• Keefe DM, Schubert MM, Elting LS et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer109(5), 820–831 (2007).
   PubMed Web of Science ®Google Scholar
• Lilleby K, Garcia P, Gooley T et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant.37(11), 1031–1035 (2006).
   PubMed Web of Science ®Google Scholar
• Mokhtar GM, Shaaban SY, Elbarbary NS, Fayed WA. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study. J. Pediatr. Hematol. Oncol.2(8), 594–600 (2010).
   Google Scholar
• Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur. J. Cancer44(11), 1507–1515 (2008).
   PubMed Web of Science ®Google Scholar
• Brogan S, Junkins S. Interventional therapies for the management of cancer pain. J. Support Oncol.8(2), 52–59 (2010).
   PubMedGoogle Scholar
• Raphael J, Hester J, Ahmedzai S et al. Cancer pain: part 2: physical, interventional and complimentary therapies; management in the community; acute, treatment-related and complex cancer pain: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med.11(6), 872–896 (2010).
   PubMed Web of Science ®Google Scholar
• Raphael J, Ahmedzai S, Hester J et al. Cancer pain: part 1: pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med.11(5), 742–764 (2010).
   PubMed Web of Science ®Google Scholar
• Niscola P, Scaramucci L, Romani C et al. Opioids in pain management of blood-related malignancies. Ann. Hematol.85(8), 489–501 (2006).
   PubMed Web of Science ®Google Scholar
• Chakraborty A, Wells R, Doherty M, Huynh C, Selby D. Joint pain in AML: successful pain control with radiotherapy. J. Pain Symptom Manage.35(6), 670–672 (2008).
   PubMed Web of Science ®Google Scholar
• Weinmann M, Becker G, Einsele H, Bamberg M. Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders. Radiother. Oncol.58, 235–246 (2001).
   PubMed Web of Science ®Google Scholar
• McFarland JT, Kuzma C, Millard FE, Johnstone PA. Palliative irradiation of the spleen. Am. J. Clin. Oncol.26, 178–183 (2003).
   PubMed Web of Science ®Google Scholar
• Haas RLM, Poortmans P, de Jong D. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J. Clin. Oncol.13, 2474–2480 (2003).
   Google Scholar
• Garland P, Gishen P, Rahemtulla A. Percutaneous vertebroplasty to treat painful myelomatous vertebral deposits-long-term efficacy outcomes. Ann. Hematol.90(1), 95–100 (2010).
   PubMed Web of Science ®Google Scholar
• Murtagh F, Edmonds P, Farnham C. Opioids in special circumstances. In: Opioids in Cancer Pain, Forbes K (Ed). Oxford University Press, Oxford, UK, 131–143 (2007).
   Google Scholar
• Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging27(5), 417–433 (2010).
   PubMed Web of Science ®Google Scholar
• Niscola P, Scaramucci L, Vischini G et al. The use of major analgesics in patients with renal dysfunction. Curr. Drug Targets11(6), 752–758 (2010).
   PubMed Web of Science ®Google Scholar
• Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin. Proc.85(5), 451–458 (2010).
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cancer Pain Relief. World Health Organization, Geneva, Switzerland (1986).
   Google Scholar
• Swarm R, Anghelescu DL, Benedetti C et al. National comprehensive cancer network (NCCN). Adult cancer pain. J. Natl Compr. Canc. Netw.5(8), 726–751 (2007).
   PubMedGoogle Scholar
• Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia12(5), 514–517 (2006).
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Böger RH, Budd K et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract.8(4), 287–313 (2008).
   PubMedGoogle Scholar
• Smith HS. Opioid metabolism. Mayo Clin. Proc.84(7), 613–624 (2009).
   PubMed Web of Science ®Google Scholar
• Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin. Pharmacokinet.43(13), 879–923 (2004).
   PubMed Web of Science ®Google Scholar
• Niscola P, Perrotti AP, del Poeta G et al. Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures. Herpes14(2), 45–47 (2007).
   PubMedGoogle Scholar
• Pergolizzi J, Aloisi AM, Dahan AA et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract.10(5), 428–450 (2010).
   PubMed Web of Science ®Google Scholar
• Cherny N, Ripamonti C, Pereira J et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J. Clin. Oncol.19(9), 2542–2554 (2001).
   PubMed Web of Science ®Google Scholar
• Pigni A, Brunelli C, Gibbins J et al. Content development for European guidelines on the use of opioids for cancer pain: a systematic review and Expert Consensus Study. Minerva Anestesiol.76(10), 833–843 (2010).
   PubMed Web of Science ®Google Scholar
• Foley KM. The treatment of cancer pain. N. Engl. J. Med.313(2), 84–95 (1985).
   PubMed Web of Science ®Google Scholar
• Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology112(1), 226–238 (2010).
   PubMed Web of Science ®Google Scholar
• Stanos SP, McLean J, Rader L. Physical medicine rehabilitation approach to pain. Med. Clin. North Am.91(1), 57–95 (2007).
   PubMed Web of Science ®Google Scholar
• Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E. Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J. Palliat. Med.11(3), 422–427 (2008).
   PubMed Web of Science ®Google Scholar